Calvin Bassey has gradually established himself in the Super Eagles squad, a team widely regarded by many football aficionados as one of the most talented collections of African footballers assembled ...

This would require greater innovation, incentives for scaling-up of bio-based solutions, and the removal of policy and infrastructure bottlenecks. Addressing the regional imbalance would also be ...

One of the biotech in­dus­try’s most well-fund­ed cell and gene ther­a­py com­pa­nies has laid off em­ploy­ees for the third year in a row.

Kill Team is finally getting a Tyranid Kill Team! And it’s ravenous. Say hello to the upcoming Kill Team Typhon Box! Kill Team’s new box has been announced. Typhon brings in two more Kill Teams. One ...

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

Boston-based Hill­star Bio on Tues­day be­came the lat­est im­munol­o­gy start­up launch, un­veil­ing a $67 mil­lion Se­ries A round ...

Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the promise ...

Tyranid bio-forms adapt and evolve at great speed, in real time, adopting whatever form necessary to evade, encircle, disable and devour their prey – whether they be a cowering, weeping child, an ...

David Sheff’s new biography convincingly argues for John Lennon’s widow as a feminist, activist, avant-garde artist and world-class sass. By Alexandra Jacobs When you purchase an independently ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

March 20 (Reuters) - Sanofi (SASY.PA), opens new tab on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201.